Search research articles
Contact Us
Filters
Showing results (31-40 of 172) with videos related to
Page
of 18
Sort By:
Arthritis and Rheumatism
|
August 1, 2008
Imatinib mesylate treatment of nephrogenic systemic fibrosis
Jonathan Kay, Whitney A High
Annual Review of Medicine
|
January 16, 2016
Gadolinium-Induced Fibrosis
Derrick J Todd, Jonathan Kay
Current Opinion in Rheumatology
|
April 25, 2024
Axial spondyloarthritis guidelines - aiming for maximum impact
Mathieu Choufani, Jonathan Kay, Joerg Ermann
Seminars in Arthritis and Rheumatism
|
May 8, 2025
Personalised treatment of rheumatoid arthritis based on cytokine profiles and synovial tissue signatures: potentials and challenges
Jérôme Avouac, Jonathan Kay, Ernest Choy
Rheumatic Diseases Clinics of North America
|
April 20, 2013
Relapsing polychondritis
Ratnesh Chopra, Nida Chaudhary, Jonathan Kay
Current Reviews in Musculoskeletal Medicine
|
June 10, 2011
Treating rheumatoid arthritis to target: an international initiative
Elana J Bernstein, Jonathan Kay, Allan Gibofsky
Rheumatic Diseases Clinics of North America
|
June 1, 2010
Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention
Sougata Karmakar, Jonathan Kay, Ellen M Gravallese
Expert Opinion on Biological Therapy
|
April 23, 2013
Rituximab biosimilars
Edward M Vital, Jonathan Kay, Paul Emery
The New England Journal of Medicine
|
November 27, 2009
Case records of the Massachusetts General Hospital. Case 37-2009. A 46-year-old woman with chronic renal failure, leg swelling, and skin changes
Daniela Kroshinsky, Jonathan Kay, Rosalynn M Nazarian
Current Reviews in Musculoskeletal Medicine
|
July 6, 2011
Erratum to: Treating rheumatoid arthritis to target: an international initiative
Elana J Bernstein, Jonathan Kay, Allan Gibofsky
Page
of 18
Search research articles
Search
Showing results (31-40 of 172) with videos related to
Sort By:
Page
of 18
Arthritis and Rheumatism
|
August 1, 2008
Imatinib mesylate treatment of nephrogenic systemic fibrosis
Jonathan Kay, Whitney A High
Annual Review of Medicine
|
January 16, 2016
Gadolinium-Induced Fibrosis
Derrick J Todd, Jonathan Kay
Current Opinion in Rheumatology
|
April 25, 2024
Axial spondyloarthritis guidelines - aiming for maximum impact
Mathieu Choufani, Jonathan Kay, Joerg Ermann
Seminars in Arthritis and Rheumatism
|
May 8, 2025
Personalised treatment of rheumatoid arthritis based on cytokine profiles and synovial tissue signatures: potentials and challenges
Jérôme Avouac, Jonathan Kay, Ernest Choy
Rheumatic Diseases Clinics of North America
|
April 20, 2013
Relapsing polychondritis
Ratnesh Chopra, Nida Chaudhary, Jonathan Kay
Current Reviews in Musculoskeletal Medicine
|
June 10, 2011
Treating rheumatoid arthritis to target: an international initiative
Elana J Bernstein, Jonathan Kay, Allan Gibofsky
Rheumatic Diseases Clinics of North America
|
June 1, 2010
Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention
Sougata Karmakar, Jonathan Kay, Ellen M Gravallese
Expert Opinion on Biological Therapy
|
April 23, 2013
Rituximab biosimilars
Edward M Vital, Jonathan Kay, Paul Emery
The New England Journal of Medicine
|
November 27, 2009
Case records of the Massachusetts General Hospital. Case 37-2009. A 46-year-old woman with chronic renal failure, leg swelling, and skin changes
Daniela Kroshinsky, Jonathan Kay, Rosalynn M Nazarian
Current Reviews in Musculoskeletal Medicine
|
July 6, 2011
Erratum to: Treating rheumatoid arthritis to target: an international initiative
Elana J Bernstein, Jonathan Kay, Allan Gibofsky
Page
of 18